Small-molecule activation of lysosomal TRP channels ameliorates Duchenne muscular dystrophy in mouse models

Duchenne muscular dystrophy (DMD) is a devastating disease caused by mutations in dystrophin that compromise sarcolemma integrity. Currently, there is no treatment for DMD. Mutations in transient receptor potential mucolipin 1 (ML1), a lysosomal Ca(2+) channel required for lysosomal exocytosis, prod...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Lu, Zhang, Xiaoli, Yang, Yexin, Li, Dan, Tang, Kaiyuan, Zhao, Zifan, He, Wanwan, Wang, Ce, Sahoo, Nirakar, Converso-Baran, Kimber, Davis, Carol S., Brooks, Susan V., Bigot, Anne, Calvo, Raul, Martinez, Natalia J., Southall, Noel, Hu, Xin, Marugan, Juan, Ferrer, Marc, Xu, Haoxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032923/
https://www.ncbi.nlm.nih.gov/pubmed/32128386
http://dx.doi.org/10.1126/sciadv.aaz2736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032923/
https://www.ncbi.nlm.nih.gov/pubmed/32128386
http://dx.doi.org/10.1126/sciadv.aaz2736

Ejemplares similares